C. Niederau

Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals

Julia Dietz, S. Süsser, Johannes Vermehren et al. · Gastroenterology · 2017 · 147 citations

Viral Hepatitis, Direct-acting Antivirals, Antiviral Therapy +8

Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B

Andreas Erhardt, Ulf Reineke, D. Blondin et al. · Journal of Hepatology · 2000 · 127 citations

Transcriptional Regulation, Hepatology, Core Promoter +8

49 PEGINTRON MAINTENANCE THERAPY IN CIRRHOTIC (METAVIR F4) HCV PATIENTS, WHO FAILED TO RESPOND TO INTERFERON/RIBAVIRN (IR) THERAPY: FINAL RESULTS OF THE EPIC3 CIRRHOSIS MAINTENANCE TRIAL

Jordi Bruix, Thierry Poynard, Massimo Colombo et al. · Journal of Hepatology · 2009 · 36 citations · Full text

Metavir F4, Hcv Patients, Hepatology +7

Pegylated interferon alfa-2B (PEG-intron) mono-therapy is superior to interferon alfa-2B (intron A) for the treatment of chronic hepatitis C

Christian Trépo, Karen L. Lindsay, C. Niederau et al. · Journal of Hepatology · 2000 · 32 citations

Hepatology, Hepatitis C, Viral Hepatitis +7

[Liver function tests in a clinical comparison].

Wolfgang Stremmel, R Wojdat, R Groteguth et al. · PubMed · 1992 · 23 citations

Galactose Elimination Capacity, Healthy Subjects, Gastroenterology +16